Anal Fissure Clinical Trial
Official title:
An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing
This is an open label study. The study will consist of 2 treatment group: coated Nifedipine suppository containing 12 mg of Nifedipine applied twice daily (group 1) and coated Nifedipine suppository containing 12 mg of Nifedipine applied once daily (group 2). Approximately 30 subjects will participate into this 8-week study. The primary objective is to examine the dose effect of coated Nifedipine suppository on Anal fissure pain and healing.
This is an open label study. The study will consist of 2 treatment group: coated Nifedipine suppository containing 12 mg of Nifedipine applied twice daily (group 1) and coated Nifedipine suppository containing 12 mg of Nifedipine applied once daily (group 2). Approximately 30 subjects will participate into this 8-week study. A screening visit will be used to determine subject suitability for inclusion in the trial. Within one week of the screening visit, subjects who meet all inclusion criteria and none of the exclusion criteria will receive Coated Nifedipine 12 mg Suppository X2 a day (BID) (24 mg/day total) OR Coated Nifedipine 12 mg Suppository X1 a day (OD) (12 mg/day total) for a period of 8 weeks. During this period, 4 study visits (at 0, 2, 5, and 8 weeks) will take place. Study medication will be administered BID (in the morning and in the evening) or OD (only in the morning). In addition to receiving study medication, subjects will be maintained on a standard treatment for Anal Fissure: sitz baths, high fiber diet. ;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06216223 -
Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients
|
N/A | |
| Not yet recruiting |
NCT05405634 -
Microbiota in Chronic Anal Fissure and Its Association With Prognosis
|
||
| Completed |
NCT05736926 -
Anal Fissure Among Survivors of COVID-19 Virus Infection.
|
||
| Enrolling by invitation |
NCT00980369 -
The Importance of Lateral Internal Sphincterotomy Incision: Parallel or Vertical
|
N/A | |
| Completed |
NCT05616455 -
Efficacy and Safety of Propionibacterium Extract Gel Versus 0.4% Glyceryl Trinitrate Ointment in the Treatment of Chronic Anal Fissure: a Randomised Controlled Trial
|
Phase 4 | |
| Completed |
NCT04173130 -
Monocentric Feasibility Study for a New Medical Device for the Treatment of Anal Fissure With Botulinum Toxin
|
N/A | |
| Completed |
NCT03345511 -
Ultrasound Guided Caudal Block for Benign Anal Surgery
|
N/A | |
| Completed |
NCT05341180 -
Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial
|
Phase 2/Phase 3 | |
| Completed |
NCT03528772 -
Topical Minoxidil Versus Topical Glyceryl Trinitrate in Treatment of Chronic Anal Fissure
|
N/A | |
| Active, not recruiting |
NCT04428697 -
Sungurtekin Technique vs. Closed Lateral Internal Sphincterotomy Technique
|
N/A | |
| Withdrawn |
NCT01920074 -
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
|
Phase 4 | |
| Recruiting |
NCT01039051 -
Diet and Lifestyle Intervention Study in Postpartum Women in China
|
Phase 2/Phase 3 | |
| Completed |
NCT00210444 -
Efficacy Study of Dysport® in the Treatment of Anal Fissure.
|
Phase 2 | |
| Completed |
NCT00827736 -
Comparison of Treatment Success of Botox Injection in the Internal Sphincter Versus Isosorbidedinitrate Ointment in Patients With an Anal Fissure
|
Phase 4 | |
| Withdrawn |
NCT02667535 -
PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure
|
Phase 1 | |
| Not yet recruiting |
NCT06049524 -
Could Preoperative Assessment of Physical and Psychological Status Help Predict Pain After Anorectal Surgery?
|
||
| Not yet recruiting |
NCT05709717 -
Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases
|
||
| Completed |
NCT05038605 -
Topical vs Oral Metronidazole After Benign Anorectal Surgery
|
N/A | |
| Not yet recruiting |
NCT03780998 -
Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases
|
||
| Completed |
NCT03426449 -
Posterolateral Versus Lateral Internal Anal Sphincterotomy for Chronic Anal Fissure
|
N/A |